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a b s t r a c t
Medulloblastoma is the most frequent malignant tumor of the central nervous system
(CNS) in children, but it can rarely occur in adults. Extraneural relapse of medulloblas-
toma occurs very rarely and it is usually associated with dismal prognosis. We present
a case of young adult with relapsed medulloblastoma with extraneural metastases in the
bone marrow and expression of terminal deoxynucleotidyl transferase (TdT) on the
malignant cells mimicking acute leukemia. To the best of our knowledge, this is the first
report of medulloblastoma exhibiting expression of the TdT in adult. We would like to
emphasize that in cases like this, differential diagnosis of anemia and thrombocytopenia
in adults should include a consideration of primary or secondary bone marrow involve-
ment by medulloblastoma or other rare malignancy.
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z o.o. All rights reserved.nervous system (CNS) in adults [1, 2]. While no clear etiology
has been identified, a link may exist with maternal diet
and blood or immune disorders during pregnancy, early
John Cunningham polyomavirus infections in childhood, or
human cytomegalovirus. The most common cytogeneticarrow Transplantation, Poznań University of Medical Sciences,
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17q), wherein the short arm (p) is absent, and there is a gain
of genetic material from the long arm (q). The search for
putative tumor suppressor genes on chromosome 17p in the
context of medulloblastoma is ongoing [2].
Medulloblastoma presents with high invasive growth
with spread of tumor cells into the leptomeningeal space
along the neuroaxis early in the course of the disease [1]. It
constitutes approximately 3% of primary CNS tumors [2].
Extraneural relapse of medulloblastoma occurs in 3–5% of
patients and it is usually associated with dismal prognosis.
Here, we describe a case of young adult with relapsed
medulloblastoma with extraneural metastases and expres-
sion of the terminal deoxynucleotidyl transferase (TdT) on
the malignant cells mimicking acute leukemia.
Case presentation
A 19-year-old man was presented with headache and
dizziness for one month. Magnetic resonance imaging (MRI)
of the brain displayed a tumor in the right hemisphere ofFig. 1 – Medulloblastoma in the bone marrow: (A) bone marrow
cytoplasmic ratio, nucleus with a dispersed chromatin structure
(B) flow cytometry result showing TdT(+)/CD45(S) cells (marked a
GFAP stain (magnification 400T); (D) trephine biopsy showing cethe cerebellum. The patient underwent surgical resection
and histopathological diagnosis of medulloblastoma (WHO
grade IV) was established. He then received adjuvant cra-
niospinal radiation therapy with a boost to the posterior
fossa.
One year later the patient complained of intense general-
ized bone pain. A positron emission tomography scanning
showed a disseminated bone marrow and bone 18F-FDG
uptake with SUVmax ranging from 3 to 8. Brain MRI revealed
no signs of cancer relapse. The patient underwent preventive
chemotherapy including carboplatin and etoposide.
Afterwards he developed prolonged anemia and throm-
bocytopenia. Bone marrow examination was performed and
bone marrow cytology showed infiltrates with blast-resem-
bling cells, mimicking morphologically low-differentiated
acute leukemia and accounting for 92% of nucleated bone
marrow cells (Fig. 1A).
However, flow cytometry of bone marrow showed that
immunophenotype of the pathological cells was CD45(),
CD56(+), CD33(), CD13(), CD117(), CD14(), MPO(), CD10
(), CD7(), cytCD79a(), and TdT(+) (Fig. 1B). Trephine
biopsy revealed an extensive mass of cells positive for the cytology. Large cells mimicking blasts with a high nuclear/
 and prominent nucleoli (MGG stain, magnification 2000T);
rea); (C) trephine biopsy disclosing cells focally positive for
lls strongly positive for CD56 stain (magnification 400T)
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(Fig. 1C), neural cell adhesion molecule (CD56) (Fig. 1D), and
neurone-specific enolase. These cells were negative with
regard to myeloid and lymphoid antigens, cytokeratin,
synaptophysin and chromogranin.
Metastases of medulloblastoma to the bone marrow were
confirmed and the patient received a palliative chemother-
apy with 3 courses of ICE (ifosfamide, carboplatin, etopo-
side). Unfortunately, he developed further metastases to
lymph nodes, spleen and liver. The patient died 3 years
after initial diagnosis of medulloblastoma.
Discussion
Medulloblastoma is the most common CNS tumor in children
(15–30% of all primary CNS tumors in childhood), while it is
extremely rare in adults [3]. The cerebellum and brain are
common sites of metastases. The main sites of extraneural
relapse are bones, bone marrow, lymph nodes, lungs, and
liver (84%, 27%, 15%, 6%, 6% of cases, respectively). In adults,
atypical metastatic sites are bones (80%) and lungs [2, 3].
Primitive neuroectodermal tumor can morphologically
mimic acute leukemia [4]. In our patient, bone marrow
cytology and histology revealed morphologically atypical cells
resembling leukemic blasts. However, both immunopheno-
type and immunohistochemical examination were consistent
with bone marrow involvement of relapsed medulloblastoma.
In the present report, the medulloblastoma cells showed
expression of the precursor lymphoid antigen TdT in flow
cytometry in the absence of other lymphoid and myeloid
antigens. In the literature cases of medulloblastoma have
been described that mimic acute leukemia and show the
expression of myeloid antigens [4]. The expression of TdT
has been described in non-hematopoietic malignancies such
as Merkel carcinoma or pulmonary small cell carcinoma [5]
and medulloblastoma in children [6]. To the best of our
knowledge, this is the first report of medulloblastoma
expressing the TdT in adult.
In cases like this, differential diagnosis of anemia and
thrombocytopenia in adults should include a consideration
of primary or secondary bone marrow involvement by
medulloblastoma or other rare malignancy [4, 7]. Never-
theless, secondary acute leukemia or parallel occurrence of
acute leukemia and medulloblastoma has also been
reported [8–10]. In such cases, the results of flow cytometry,
immunohistochemical staining, and sometimes genetic ana-
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